We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Isolation and characterization of microplastics from human blood samples by confocal RAMAN microscopy
AI summary Read the abstract
Scientists have developed a new method to reliably detect tiny plastic particles called microplastics in human blood samples. Using this technique, they found plastic particles from materials like polystyrene and polyethylene in blood, confirming that these microscopic plastics can enter our bloodstream. While we still don't know the full health effects, this research gives us better tools to study how much plastic pollution is getting into our bodies and potentially affecting our health.
Microplastics (MPs) and nanoplastics (NPs) are emerging environmental contaminants increasingly detected in human tissues and fluids, highlighting the need for reliable analytical methods capable of isolating and characterizing these particles in complex biological matrices while reducing contamination risks. This work presents a systematic, integrative, and reproducible protocol for detecting MPs in human blood using confocal Raman microscopy. The method incorporates strict contamination-control measures, includes negative and positive controls to ensure analytical reliability, and provides reference Raman spectra from commonly used clinical and laboratory materials to identify potential sources of cross-contamination. Spectral data are compared using the open-source platform Open Specy, enabling similarity matching with an extensive polymer database and improving the confidence of particle identification. Application of the protocol enabled the detection and characterization of MPs in human blood samples, identifying polymers such as polystyrene (PS), ethylene-vinyl acetate (EVA), and polyethylene (PE). Overall, this protocol demonstrates high specificity for detecting MPs in human blood and provides a robust framework for future exposure studies. • Provides a contamination-controlled analytical framework for MP detection in human blood. • Integrates reference materials and controls to ensure data reliability and trace contamination sources. • Uses open-source spectral comparison to support confident polymer identification. Schematic workflow of the proposed three-step protocol for the isolation and characterization of microplastics (MPs) in human blood. The procedure integrates: (1) MPs decontamination and quality control, including the use of negative controls (NC), plastic-free materials, and contamination-minimization measures; (2) sample processing, involving blood collection, digestion, and filtration to retain MPs (<5 mm); and (3) MPs identification by confocal Raman microscopy, enabling reliable detection and classification through comparison with spectral libraries. This approach highlights the simplicity, reproducibility, and contamination-minimized nature of the method. Figure created with BioRender.com.
More Papers Like This
Advancing pyrolysis-gas chromatography-mass spectrometry for the accurate quantification of micro- and nanoplastics in human blood
AI summary Read the abstract
Researchers developed and refined pyrolysis-gas chromatography-mass spectrometry (a technique that heats plastics to identify their chemical fingerprints) to more accurately measure micro- and nanoplastics directly in human blood. Improving this method is critical because reliable detection in biological samples is a key step toward understanding how much plastic exposure humans are actually experiencing.
Quantitation of micro and nanoplastics in human blood by pyrolysis-gas chromatography–mass spectrometry
AI summary Read the abstract
Researchers developed and validated an improved method using pyrolysis-gas chromatography to measure specific plastic polymer types in human blood, detecting plastics in 64 out of 68 blood samples tested with a mean concentration of 268 nanograms per milliliter. Polyethylene was the most common polymer found, underscoring that microplastic and nanoplastic particles are already circulating inside the human body.
Quantifying micro- and nanoplastics in blood, urine, and soft tissues using optimized cascaded microfiltration and pyrolysis-GC/MS for exposomic investigations
AI summary Read the abstract
Scientists developed a more precise way to detect and measure tiny plastic particles (microplastics and even smaller nanoplastics) in blood and body tissues, then used it to confirm these particles are present in human blood, with a typical amount around 0.8 micrograms per milliliter. This matters because it gives researchers a more reliable tool to track how much plastic is building up in our bodies over time—an important first step before scientists can figure out what health effects, if any, this exposure might cause.
Microplastics in human blood: Polymer types, concentrations and characterisation using μFTIR
AI summary Read the abstract
Scientists analyzed blood from 20 healthy volunteers and found microplastics in 90% of samples, identifying 24 different plastic types including many reported for the first time in blood. The particles were mostly small fragments averaging about 128 micrometers long, and the study also detected hormone-disrupting chemicals called phthalates attached to the plastics. This adds to growing evidence that a wide variety of plastic particles are circulating in human blood.
Improved multivariate quantification of plastic particles in human blood using non-targeted pyrolysis GC-MS
AI summary Read the abstract
Scientists developed improved methods for measuring plastic particles in human blood, finding that standard techniques can produce significant errors, especially for PET plastic. The new multivariate approach reduced measurement errors by up to 38%, which is important because accurate blood measurements are essential for understanding how much microplastic exposure people actually face.
Research digests by email
When a large batch of papers lands in the Atlas, we read through it and send a short write-up of what stood out.